G01N 2333/295
From chlamydiales
Official title: from Chlamydiales (o)
G01N2333/295 (From chlamydiales) appears on 44 US grants and 64 published applications in this corpus.
Search patents in G01N- Granted patents
- 44
- Published applications
- 64
- Assignees
- 40
- Inventors
- 101
- Latest grant
- 21 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 2 |
| 2002 | 0 | 1 |
| 2003 | 2 | 5 |
| 2004 | 1 | 4 |
| 2005 | 2 | 7 |
| 2006 | 1 | 4 |
| 2007 | 1 | 6 |
| 2008 | 3 | 2 |
| 2009 | 3 | 1 |
| 2010 | 5 | 5 |
| 2011 | 1 | 4 |
| 2012 | 3 | 4 |
| 2013 | 3 | 5 |
| 2014 | 3 | 2 |
| 2015 | 1 | 3 |
| 2016 | 0 | 1 |
| 2017 | 3 | 1 |
| 2018 | 0 | 2 |
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method and device of using aqueous two-phase systems (ATPS) for enhancing diagnostics for sexually transmitted infections21 Mar 2023US 11,609,232 B2Phase Diagnostics, Inc.
- Chlamydia antigens21 Jul 2020US 10,716,842 B2Glaxosmithkline Biologicals SA
- Methods and antisera for isolating and identifying subsets of CD8 T cells26 May 2020US 10,663,467 B2
- Method and peptides for the detection of Chlamydia suis27 Aug 2019US 10,393,742 B2Universiteit Gent
- Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses27 Jun 2017US 9,689,018 B2Diagnostic Hybrids, Inc.
- Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely26 Mar 2026US 2026/0086092 A1
- Reliable and Scalable Methods of Detection and Platform for Consumer Medical Devices18 Jul 2024US 2024/0238778 A1Simple Healthkit, Inc.
- Method and device of using aqueous two-phase systems (ATPS) for enhancing diagnostics for sexually transmitted infections5 Nov 2020US 2020/0348303 A1Phase Diagnostics, Inc.
- Bacteria causing sexually-transmitted diseases and immune t-cell detection10 Sep 2020US 2020/0284790 A1Essenlix Corporation
- Chlamydia antigens19 Sep 2019US 2019/0282685 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- Methods and kits for the amplification of thin film based assays158US 5,955,377 ABiostar, Inc. · 1999
- Mixed cell diagnostic systems26US 6,280,928 B1Diagnostic Hybrids, Inc. · 2001
- Chlamydia major outer membrane protein23US 5,770,714 AChiron Corporation · 1998
- Treatment and diagnosis of alzheimer's disease20US 7,189,703 B2Intracell, LLC · 2007
- Diagnosing chlamydia infections with Re-lipopolysaccharide complexed to carrier or antibody thereto19US 4,652,518 AOrion Corporation · 1987